Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease

Jielin Xu,Chengsheng Mao,Yuan Hou,Yuan Luo,Jessica L. Binder,Yadi Zhou,Lynn M. Bekris,Jiyoung Shin,Ming Hu,Fei Wang,Charis Eng,Tudor I. Oprea,Margaret E. Flanagan,Andrew A. Pieper,Jeffrey Cummings,James B. Leverenz,Feixiong Cheng

DOI: https://doi.org/10.1016/j.celrep.2022.111717

IF: 8.8

2022-11-30

Cell Reports

Abstract:Xu et al. develop an interpretable deep learning framework (termed NETTAG) to identify Alzheimer's disease (AD) risk genes and drug targets through leveraging GWAS, multimodal genomics, and human protein-protein interactome network data. Combining human interactome network-based prediction and EHR-based patient data validation identifies gemfibrozil's effect on reduced incidence of AD.

cell biology